AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
HONG KONG SAR - Media OutReach Newswire - 30 October 2024 - AIM Vaccine (06660.HK), the leader in Chinese mRNA...
Read moreDetailsHONG KONG SAR - Media OutReach Newswire - 30 October 2024 - AIM Vaccine (06660.HK), the leader in Chinese mRNA...
Read moreDetailsHONG KONG SAR - Media OutReach Newswire - 30 October 2024 - The Hong Kong Institute of Surveyors Building Surveying...
Read moreDetailsJAKARTA, INDONESIA - Media OutReach Newswire - 30 October 2024 - AstraZeneca, a leading research-based multinational pharmaceutical and biopharmaceutical company,...
Read moreDetailsLaptops are great for working on the go, but using an external monitor with your laptop closed can create a...
Read moreDetailsInterest in low-earth-orbit satellite Internet service by Starlink has been rapidly growing, especially across Africa, where access to high-speed Internet...
Read moreDetails